Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BASF and Takeda Chemical Industries

This article was originally published in The Tan Sheet

Executive Summary

German and Japanese firms announce July 28 they will combine their bulk vitamins businesses. Following regulatory approvals, the combined operation will have an estimated 30% share of the worldwide vitamins market, the companies report. BASF sales to the pharmaceutical, food and animal nutrition industries totaled roughly $500 mil. in 1999; Takeda's global sales to the same industries were approximately $240 mil. The proposed merger closely follows a landmark vitamin price-fixing case in which both BASF and Takeda pleaded guilty (1"The Tan Sheet" Sept. 13, 1999, p. 4)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel